Jacobs Levy Equity Management, Inc Corbus Pharmaceuticals Holdings, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.6 - $1.11 $68,679 - $127,057
-114,466 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$1.01 - $1.82 $115,610 - $208,328
114,466 New
114,466 $117,000
Q3 2020

Nov 16, 2020
SELL
$1.5 - $9.38 $176,412 - $1.1 Million
-117,608 Closed
0 $0
Q2 2020

Aug 17, 2020
BUY
$4.79 - $8.39 $366,003 - $641,079
76,410 Added 185.47%
117,608 $987,000
Q1 2020

May 15, 2020
BUY
$3.44 - $7.21 $141,721 - $297,037
41,198 New
41,198 $216,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email